ATRC logo

ATRC AtriCure, Inc.

NASDAQ Global Market · Medical - Instruments & Supplies · Healthcare

$55.45
+0.43 (+0.78%)

AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies. These include Isolator Synergy Clamps, which are single-use radiofrequency products. Its multifunctional pens…

Market Cap: $2.82Bwww.atricure.com

Price

$41.39+47.24%
$25.86$31.04$36.21$41.39
Apr 30Aug 7

Social Signal Score

59
5d
—
30d
60
7 mentions
+0.0%
60d
60
7 mentions
+0.0%
90d
59
9 mentions
+0.0%
news: 9

Analyst Ratings

20 analysts
Buyconsensus
Strong Buy 0Buy 17Hold 3Sell 0Strong Sell 0
Avg price target$62+11.8%
Low $50Median $64High $70
Current Consensus

Revenue

$154.45M+275.27%
$40.82M$78.70M$116.57M$154.45M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-0.36
$-0.40–$-0.31
4 analysts
FY2026
$0.23
$0.15–$0.27
6 analysts
FY2027
$0.47+104% YoY
$0.37–$0.51
7 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Michael H. Carrel
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
1,350
Beta
1.21
Country
US
Piotroski score
8 / 9 (Strong)
Altman Z-score
9.71
www.atricure.com